igg enzyme linked immunosorbent assay elisa kits  (ZeptoMetrix)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ZeptoMetrix igg enzyme linked immunosorbent assay elisa kits
    Nuclear protein (NP)–specific plasmablast responses to live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV). A , Frequency of NP-specific immunoglobulin A (IgA) and immunoglobulin G <t>(IgG)</t> antibody-secreting cells (ASCs) (left panels) and percentage of NP-specific ASCs among total vaccine-specific ASCs (right panels) after immunization with 2011 LAIV or IIV. The NP-specific ASCs were measured with enzyme-linked <t>immunosorbent</t> spot plates coated with recombinant NP. B , Binding activity of NP-specific IgG plasmablast-derived polyclonal antibodies (PPAbs) from recipients of 2010 IIV or recipient of 2010 LAIV (left panel) and relative NP binding activity normalized to HA (H1N1) binding activity (right panel). The binding activity was calculated as the area under curve (AUC) of serially diluted PPAb samples, using an enzyme-linked immunosorbent assay <t>(ELISA)</t> with recombinant NP- or HA-coated ELISA plates, starting at a dilution of 1:100 for NP or 1:1000 for HA. Bars indicate geometric means. Means were compared between IIV and LAIV groups by an unpaired t test or by fitting a regression model, using the generalized maximum entropy approach.
    Igg Enzyme Linked Immunosorbent Assay Elisa Kits, supplied by ZeptoMetrix, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/igg enzyme linked immunosorbent assay elisa kits/product/ZeptoMetrix
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    igg enzyme linked immunosorbent assay elisa kits - by Bioz Stars, 2020-07
    86/100 stars

    Images

    1) Product Images from "Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines"

    Article Title: Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines

    Journal: The Journal of Infectious Diseases

    doi: 10.1093/infdis/jiu190

    Nuclear protein (NP)–specific plasmablast responses to live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV). A , Frequency of NP-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) (left panels) and percentage of NP-specific ASCs among total vaccine-specific ASCs (right panels) after immunization with 2011 LAIV or IIV. The NP-specific ASCs were measured with enzyme-linked immunosorbent spot plates coated with recombinant NP. B , Binding activity of NP-specific IgG plasmablast-derived polyclonal antibodies (PPAbs) from recipients of 2010 IIV or recipient of 2010 LAIV (left panel) and relative NP binding activity normalized to HA (H1N1) binding activity (right panel). The binding activity was calculated as the area under curve (AUC) of serially diluted PPAb samples, using an enzyme-linked immunosorbent assay (ELISA) with recombinant NP- or HA-coated ELISA plates, starting at a dilution of 1:100 for NP or 1:1000 for HA. Bars indicate geometric means. Means were compared between IIV and LAIV groups by an unpaired t test or by fitting a regression model, using the generalized maximum entropy approach.
    Figure Legend Snippet: Nuclear protein (NP)–specific plasmablast responses to live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV). A , Frequency of NP-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) (left panels) and percentage of NP-specific ASCs among total vaccine-specific ASCs (right panels) after immunization with 2011 LAIV or IIV. The NP-specific ASCs were measured with enzyme-linked immunosorbent spot plates coated with recombinant NP. B , Binding activity of NP-specific IgG plasmablast-derived polyclonal antibodies (PPAbs) from recipients of 2010 IIV or recipient of 2010 LAIV (left panel) and relative NP binding activity normalized to HA (H1N1) binding activity (right panel). The binding activity was calculated as the area under curve (AUC) of serially diluted PPAb samples, using an enzyme-linked immunosorbent assay (ELISA) with recombinant NP- or HA-coated ELISA plates, starting at a dilution of 1:100 for NP or 1:1000 for HA. Bars indicate geometric means. Means were compared between IIV and LAIV groups by an unpaired t test or by fitting a regression model, using the generalized maximum entropy approach.

    Techniques Used: ELISpot Assay, Recombinant, Binding Assay, Activity Assay, Derivative Assay, Enzyme-linked Immunosorbent Assay

    Cross-reactive hemagglutinin (HA) binding activity of plasmablast-derived polyclonal antibodies (PPAbs) after immunization with 2010 inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). A pool of PPAbs was assembled by combining equal amounts of immunoglobulin G (IgG) from each PPAb sample in the IIV or LAIV groups. Each PPAb pool was serially diluted, starting at a concentration of 9 ng/mL for LAIV and 4.1 ng/mL for IIV of IgG, and analyzed with an enzyme-linked immunosorbent assay (ELISA) for binding to recombinant HAs from indicated influenza virus strains. Relative binding activity to each HA (numbers in each panel) was defined as the ratio of its area under curve (AUC) to that of the relevant 2010 vaccine strain (circle in each panel, assigned a value of 1).
    Figure Legend Snippet: Cross-reactive hemagglutinin (HA) binding activity of plasmablast-derived polyclonal antibodies (PPAbs) after immunization with 2010 inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). A pool of PPAbs was assembled by combining equal amounts of immunoglobulin G (IgG) from each PPAb sample in the IIV or LAIV groups. Each PPAb pool was serially diluted, starting at a concentration of 9 ng/mL for LAIV and 4.1 ng/mL for IIV of IgG, and analyzed with an enzyme-linked immunosorbent assay (ELISA) for binding to recombinant HAs from indicated influenza virus strains. Relative binding activity to each HA (numbers in each panel) was defined as the ratio of its area under curve (AUC) to that of the relevant 2010 vaccine strain (circle in each panel, assigned a value of 1).

    Techniques Used: Binding Assay, Activity Assay, Derivative Assay, Concentration Assay, Enzyme-linked Immunosorbent Assay, Recombinant

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines
    Article Snippet: .. The concentrations of IgA and IgG in PPAbs were determined with the Immuno-Tek Quantitative Human IgA or IgG enzyme-linked immunosorbent assay (ELISA) kits (Zeptometrix), respectively. ..

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    ZeptoMetrix igg enzyme linked immunosorbent assay elisa kits
    Nuclear protein (NP)–specific plasmablast responses to live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV). A , Frequency of NP-specific immunoglobulin A (IgA) and immunoglobulin G <t>(IgG)</t> antibody-secreting cells (ASCs) (left panels) and percentage of NP-specific ASCs among total vaccine-specific ASCs (right panels) after immunization with 2011 LAIV or IIV. The NP-specific ASCs were measured with enzyme-linked <t>immunosorbent</t> spot plates coated with recombinant NP. B , Binding activity of NP-specific IgG plasmablast-derived polyclonal antibodies (PPAbs) from recipients of 2010 IIV or recipient of 2010 LAIV (left panel) and relative NP binding activity normalized to HA (H1N1) binding activity (right panel). The binding activity was calculated as the area under curve (AUC) of serially diluted PPAb samples, using an enzyme-linked immunosorbent assay <t>(ELISA)</t> with recombinant NP- or HA-coated ELISA plates, starting at a dilution of 1:100 for NP or 1:1000 for HA. Bars indicate geometric means. Means were compared between IIV and LAIV groups by an unpaired t test or by fitting a regression model, using the generalized maximum entropy approach.
    Igg Enzyme Linked Immunosorbent Assay Elisa Kits, supplied by ZeptoMetrix, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/igg enzyme linked immunosorbent assay elisa kits/product/ZeptoMetrix
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    igg enzyme linked immunosorbent assay elisa kits - by Bioz Stars, 2020-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    Nuclear protein (NP)–specific plasmablast responses to live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV). A , Frequency of NP-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) (left panels) and percentage of NP-specific ASCs among total vaccine-specific ASCs (right panels) after immunization with 2011 LAIV or IIV. The NP-specific ASCs were measured with enzyme-linked immunosorbent spot plates coated with recombinant NP. B , Binding activity of NP-specific IgG plasmablast-derived polyclonal antibodies (PPAbs) from recipients of 2010 IIV or recipient of 2010 LAIV (left panel) and relative NP binding activity normalized to HA (H1N1) binding activity (right panel). The binding activity was calculated as the area under curve (AUC) of serially diluted PPAb samples, using an enzyme-linked immunosorbent assay (ELISA) with recombinant NP- or HA-coated ELISA plates, starting at a dilution of 1:100 for NP or 1:1000 for HA. Bars indicate geometric means. Means were compared between IIV and LAIV groups by an unpaired t test or by fitting a regression model, using the generalized maximum entropy approach.

    Journal: The Journal of Infectious Diseases

    Article Title: Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines

    doi: 10.1093/infdis/jiu190

    Figure Lengend Snippet: Nuclear protein (NP)–specific plasmablast responses to live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV). A , Frequency of NP-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) (left panels) and percentage of NP-specific ASCs among total vaccine-specific ASCs (right panels) after immunization with 2011 LAIV or IIV. The NP-specific ASCs were measured with enzyme-linked immunosorbent spot plates coated with recombinant NP. B , Binding activity of NP-specific IgG plasmablast-derived polyclonal antibodies (PPAbs) from recipients of 2010 IIV or recipient of 2010 LAIV (left panel) and relative NP binding activity normalized to HA (H1N1) binding activity (right panel). The binding activity was calculated as the area under curve (AUC) of serially diluted PPAb samples, using an enzyme-linked immunosorbent assay (ELISA) with recombinant NP- or HA-coated ELISA plates, starting at a dilution of 1:100 for NP or 1:1000 for HA. Bars indicate geometric means. Means were compared between IIV and LAIV groups by an unpaired t test or by fitting a regression model, using the generalized maximum entropy approach.

    Article Snippet: The concentrations of IgA and IgG in PPAbs were determined with the Immuno-Tek Quantitative Human IgA or IgG enzyme-linked immunosorbent assay (ELISA) kits (Zeptometrix), respectively.

    Techniques: ELISpot Assay, Recombinant, Binding Assay, Activity Assay, Derivative Assay, Enzyme-linked Immunosorbent Assay

    Cross-reactive hemagglutinin (HA) binding activity of plasmablast-derived polyclonal antibodies (PPAbs) after immunization with 2010 inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). A pool of PPAbs was assembled by combining equal amounts of immunoglobulin G (IgG) from each PPAb sample in the IIV or LAIV groups. Each PPAb pool was serially diluted, starting at a concentration of 9 ng/mL for LAIV and 4.1 ng/mL for IIV of IgG, and analyzed with an enzyme-linked immunosorbent assay (ELISA) for binding to recombinant HAs from indicated influenza virus strains. Relative binding activity to each HA (numbers in each panel) was defined as the ratio of its area under curve (AUC) to that of the relevant 2010 vaccine strain (circle in each panel, assigned a value of 1).

    Journal: The Journal of Infectious Diseases

    Article Title: Distinct Cross-reactive B-Cell Responses to Live Attenuated and Inactivated Influenza Vaccines

    doi: 10.1093/infdis/jiu190

    Figure Lengend Snippet: Cross-reactive hemagglutinin (HA) binding activity of plasmablast-derived polyclonal antibodies (PPAbs) after immunization with 2010 inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). A pool of PPAbs was assembled by combining equal amounts of immunoglobulin G (IgG) from each PPAb sample in the IIV or LAIV groups. Each PPAb pool was serially diluted, starting at a concentration of 9 ng/mL for LAIV and 4.1 ng/mL for IIV of IgG, and analyzed with an enzyme-linked immunosorbent assay (ELISA) for binding to recombinant HAs from indicated influenza virus strains. Relative binding activity to each HA (numbers in each panel) was defined as the ratio of its area under curve (AUC) to that of the relevant 2010 vaccine strain (circle in each panel, assigned a value of 1).

    Article Snippet: The concentrations of IgA and IgG in PPAbs were determined with the Immuno-Tek Quantitative Human IgA or IgG enzyme-linked immunosorbent assay (ELISA) kits (Zeptometrix), respectively.

    Techniques: Binding Assay, Activity Assay, Derivative Assay, Concentration Assay, Enzyme-linked Immunosorbent Assay, Recombinant